Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Chapman

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
American Journal of Respiratory Cell and Molecular Biology|November 20, 2001
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic miceT T Kung, B Luo, Y Crawley, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Interferon-gamma and antibodies to interleukin-5 and interleukin-4 inhibit the pulmonary eosinophilia in allergic miceT T Kung, D M Stelts, J A Zurcher, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonistD C Bolser, D J Blythin, R W Chapman, et al.
International Archives of Allergy and Immunology|September 1, 1994
Characterization of a murine model of allergic pulmonary inflammationT T Kung, H Jones, G K Adams, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 1995
Effects of an antibody to interleukin-5 in a monkey model of asthmaP J Mauser, A M Pitman, X Fernandez, et al.
Pharmacology|January 1, 1997
Sch 37224, an experimental antiallergy compound, inhibits the neuropeptide component of hyperventilation- and nicotine-induced bronchoconstriction in guinea pigsP J Mauser, C Rasquinha, J A Hey, et al.
Gastroenterology|April 1, 1996
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapyC J Healey, N K Sabharwal, J Daub, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamineM M Billah, R W Chapman, R W Egan, et al.
American Journal of Respiratory Cell and Molecular Biology|September 1, 1995
Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibodyT T Kung, D M Stelts, J A Zurcher, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.
American Journal of Respiratory Cell and Molecular Biology|November 20, 2001
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic miceT T Kung, B Luo, Y Crawley, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Interferon-gamma and antibodies to interleukin-5 and interleukin-4 inhibit the pulmonary eosinophilia in allergic miceT T Kung, D M Stelts, J A Zurcher, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonistD C Bolser, D J Blythin, R W Chapman, et al.
International Archives of Allergy and Immunology|September 1, 1994
Characterization of a murine model of allergic pulmonary inflammationT T Kung, H Jones, G K Adams, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 1995
Effects of an antibody to interleukin-5 in a monkey model of asthmaP J Mauser, A M Pitman, X Fernandez, et al.
Pharmacology|January 1, 1997
Sch 37224, an experimental antiallergy compound, inhibits the neuropeptide component of hyperventilation- and nicotine-induced bronchoconstriction in guinea pigsP J Mauser, C Rasquinha, J A Hey, et al.
Gastroenterology|April 1, 1996
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapyC J Healey, N K Sabharwal, J Daub, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamineM M Billah, R W Chapman, R W Egan, et al.
American Journal of Respiratory Cell and Molecular Biology|September 1, 1995
Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibodyT T Kung, D M Stelts, J A Zurcher, et al.
Pageof 23